nicardipine has been researched along with Neoplasms in 1 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Developing drugs with anticancer activity and low toxic side-effects at low costs is a challenging issue for cancer chemotherapy." | 1.48 | Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation. ( Akiyoshi, S; Hirose, L; Iwata, M; Kohara, H; Liao, J; Sawada, R; Tani, K; Yamanishi, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, M | 1 |
| Hirose, L | 1 |
| Kohara, H | 1 |
| Liao, J | 1 |
| Sawada, R | 1 |
| Akiyoshi, S | 1 |
| Tani, K | 1 |
| Yamanishi, Y | 1 |
1 other study available for nicardipine and Neoplasms
| Article | Year |
|---|---|
Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
Topics: Antineoplastic Agents; Computational Biology; Drug Repositioning; Neoplasms | 2018 |